Lung cancercardiovascular diseaseMACECOPDacute myocardial infarctionMACE-freestrokeunstable anginaNCT03934866airflow obstruction
…Introduction Lung cancer and cardiovascular disease are leading causes of death in indiv…
Browse by entity family
An entity family is a category of extracted information. Choose one to browse its named entities and supporting articles.
Funders
Organisations named as supporting, sponsoring, or funding research.
5,089 articles · 9,137 mentionsInstitutionsUniversities, hospitals, research centres, networks, and public bodies.
11,350 articles · 22,378 mentionsDrugsNamed medicines, compounds, vaccines, and pharmacological agents.
10,506 articles · 58,393 mentionsDiseasesNamed diseases, disorders, syndromes, injuries, and health conditions.
23,712 articles · 125,551 mentionsTreatmentsClinical therapies and care approaches used to manage a condition.
7,227 articles · 16,644 mentionsInterventionsProgrammes, procedures, policies, and other actions being evaluated.
4,132 articles · 9,994 mentionsClinical instrumentsNamed questionnaires, scales, scores, indices, and other clinical outcome assessments.
945 articles · 1,957 mentions29,499matching articles
244,054matching entity mentions
30popular entities listed
0%of mentions human-reviewed
Popular entities in these results
Choose an entity to see the articles in which it was identified.
EMBASE784PUBMED717COVID-19645Cancer605SLE570Diabetes552NHS522WEB OF SCIENCE499Hypertension418SCOPUS417HIV406Systemic Lupus Erythematosus390Heart Failure364Asthma349Stroke336COPD331WHO330Colorectal Cancer327Cardiovascular Disease317Type 2 Diabetes316Chronic Obstructive Pulmonary Disease313Joanna Briggs Institute306MEDLINE306Atrial Fibrillation283Cochrane Library275Breast Cancer271Hepatocellular Carcinoma253SSc251Inflammatory Bowel Disease250Obesity246
Matching articles
29,499 articles · page 178 of 2459TreprostinilnerandomilastnintedanibIdiopathic Pulmonary Fibrosis (IPF)pulmonary hypertensionpirfenidone
…and hydroxyproline content levels in the PCLS model.Conclusions Treprostinil inhibits RhoA activation and this may be via PPARβδ activation.…
COPDChronic obstructive pulmonary diseaseEPO
…median ± IQR. *P ≤ 0.037Conclusion Overall, data suggest primed COPD blood-derived eosinophils enter the lung via more efficient con…
Amrita Institute of Medical SciencescirrhosisfrailtyL-isoleucinehepatic fibrosishepatic encephalopathyL-valineleucineBCAA supplementation
…atients.Methods A randomized prospective study was conducted at Amrita Institute of Medical Sciences on 70 Cirrhotic patients (33 in the intervention group receivin…
98.5%
Male infertilityChlorpyrifoslycopeneCPFCPF-treatedCPF-induced
…e of damaging effect on human, animal health and environmental. Male infertility is one of the major problems throughout the world and extensive…
recurrent/metastatic head and neck squamous cell carcinomaSPFQ-CSPFQ-BSPFQ-ASPFQEastern Cooperative Oncology Group
… from October 2020 to October 2022.Participants 371 adults with recurrent/metastatic head and neck squamous cell carcinoma (39% aged >66 years, 69% White and 81% male).Primary outcome me…
intravenous milrinoneMilrinoneAgence Nationale de Sécurité du MédicamentArterial vasospasmcerebral ischaemiaANSMSubarachnoid haemorrhageCNILSAHComité de Protection des Personnes Ouest V+1 more
… first multicentre randomised study to evaluate the efficacy of intravenous milrinone in improving the neurological outcomes at 3 months in patients …
lemborexantbuprenorphineVirginia Commonwealth University Institutional Review Boardopioid use disorderinsomniaBUPOUDFood and Drug AdministrationFDAFDA
…or at least 4 weeks will be randomly assigned to receive either lemborexant (n=50) or placebo (n=50) for 8 weeks. Participants will complet…
strokeintravenous thrombolysisendovascular thrombectomymechanical thrombectomythrombolytic agentsCSAMEDLINEreperfusion therapy
… substantial benefits in improving early outcomes for ischaemic stroke. Recent clinical trials have validated the safety and efficacy …
99.5%
breast cancermemantinedocetaxeltaxanesdocetaxel-inducedAC-T regimenIRCT20160310026998N9
…/day may exhibit a potential preventive effect in patients with breast cancer undergoing treatment with docetaxel as part of their chemothera…
targeted therapiesbreast cancerround cell sarcomasEWSR1::non-ETS fusionsWHOgliomascentral nervous system tumoursCancer
…curacy, refines prognostic stratification and opens the door to targeted therapies. However, this ideal is unattainable in most low-income and mid…
frexalimabfrexalimab1200mgfrexalimab300mgpwRMSrelapsing multiple sclerosisNCT04879628COVID-19
…628) in participants with relapsing multiple sclerosis (pwRMS), frexalimab was well-tolerated and efficacious, with 1200-mg intravenous (I…